Attached files

file filename
EX-99 - NEWS RELEASE OF ACCENTURE, DATED MAY 7, 2014 - Accenture plcexhibitto8-kplcxmay72014.htm


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
____________________ 
Form 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
 ____________________
Date of Report (Date of earliest event reported): May 7, 2014
Accenture plc
(Exact name of Registrant as specified in its charter)
 
Ireland
 
001-34448
 
98-0627530
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
1 Grand Canal Square,
Grand Canal Harbour,
Dublin 2, Ireland
(Address of principal executive offices)
Registrant’s telephone number, including area code: (353) (1) 646-2000
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 








Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 7, 2014, Accenture plc (the “Company”) announced that Stephen J. Rohleder will assume the role of the Company’s group chief executive–North America, which is a newly created position, and step down as group chief executive–Health & Public Service, both effective June 1, 2014. Daniel T. London will succeed Mr. Rohleder as group chief executive–Health & Public Service, also effective June 1, 2014.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

99     News Release of Accenture plc, dated May 7, 2014






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date: May 7, 2014
ACCENTURE PLC
 
 
 
 
 
By:
 
/s/ Julie Spellman Sweet
 
Name:  
 
Julie Spellman Sweet
 
Title:
 
General Counsel, Secretary & Chief Compliance Officer





EXHIBIT INDEX

Exhibit No.
Description
99
News Release of Accenture plc, dated May 7, 2014